澳大利亚的儿科住院情况:一项纵向生态研究,1998年至2019年
Esra' O Taybeh1, Alaa A Alsharif2, Abdallah Y Naser1
1Department of Applied Pharmaceutical Sciences and Clinical Pharmacy, Faculty of Pharmacy, Isra University, Amman, Jordan.
Medicine
|March 13, 2026
概括
澳大利亚的儿科住院病例从1998年至2019年增长了23%,同日住院病例更多,女性住院率更高. 呼吸系统疾病是最常见的,突出了预防和心理健康服务的需求.
科学领域:
- 公共卫生 公共卫生
- 儿科医学 儿科医学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 了解儿科住院趋势对于有效的医疗保健规划和资源配置至关重要.
- 以前的研究表明,儿科医疗保健利用率发生了变化,需要更新分析.
- 澳大利亚的医疗保健系统在管理儿科健康需求方面面临着不断变化的挑战.
研究的目的:
- 确定澳大利亚儿科住院最常见的原因和趋势.
- 分析22年 (1998-2019) 期间住院率,入院类型 (当天 vs 过夜) 和人口结构模式的变化.
- 为儿童群体提供有针对性的公共卫生干预和医疗保健策略的信息.
主要方法:
- 使用澳大利亚国家医院发病率数据库的生态研究设计.
- 分析了儿科人口中16966610例报告的住院病例.
- 从1998年到2019年,研究了每年入院的趋势,同日住宿与过夜住宿,主要诊断和性别特定率的趋势.
主要成果:
- 在1998年至2019年期间,儿童医院每年的住院病例总数增加了23.0%.
- 当天入院人数增长了22.1%,而过夜入院人数下降了9.7%.
- 呼吸系统疾病是主要原因 (15.1%),与男性 (0.1%) 相比,女性住院率显著增加 (6.1%).
结论:
- 尽管入院人数增加,但整体住院率保持稳定,表明转向不那么密集的护理.
- 同一天住院病例的增加和女性的更高率需要量身定制的医疗保健方法.
- 呼吸系统疾病的流行和青少年住院病例的增加,特别是女性,强调需要加强预防,家长指导,伤害预防和青少年心理健康服务.
相关概念视频
02:20Longitudinal Research
13.6K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.6K
01:26Longitudinal Studies
614
Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
614
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
631
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
631
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
419
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
419
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
349
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
349
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
312
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312